High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level

High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level

Resistance to doxorubicin (DOX) remains a big challenge to breast cancer treatment especially for triple negative breast cancer (TNBC). Our previous study revealed that the antioxidant system plays an important role in conferring metastasis derived DOX resistance. In this study, we used two-dimensio...

Descripció completa

Dades bibliogràfiques
Autors principals: Luo, Man, Fu, Afu, Wu, Renfei, Wei, Na, Song, Kai, Lim, Sierin, Luo, Kathy Qian
Altres autors: Interdisciplinary Graduate School (IGS)
Format: Journal Article
Idioma:English
Publicat: 2022
Matèries:
Engineering::Bioengineering
Triple Negative Breast Cancer
Metastasis
Accés en línia:https://hdl.handle.net/10356/161346

Internet

https://hdl.handle.net/10356/161346

Ítems similars